APA

Remke M., Pfister S., Kox C., Toedt G., Becker N., Benner A., Werft W., Breit S., Liu S., Engel F., Wittmann A., Zimmermann M., Stanulla M., Schrappe M., Ludwig W., Bartram C. R., Radlwimmer B., Muckenthaler M. U., Lichter P. & Kulozik A. E. (20090921). High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. : Blood.

Chicago

Remke Marc, Pfister Stefan, Kox Corinne, Toedt Grischa, Becker Natalia, Benner Axel, Werft Wiebke, Breit Stephen, Liu Shuangyou, Engel Felix, Wittmann Andrea, Zimmermann Martin, Stanulla Martin, Schrappe Martin, Ludwig Wolf-Dieter, Bartram Claus R, Radlwimmer Bernhard, Muckenthaler Martina U, Lichter Peter and Kulozik Andreas E. 20090921. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. : Blood.

Harvard

Remke M., Pfister S., Kox C., Toedt G., Becker N., Benner A., Werft W., Breit S., Liu S., Engel F., Wittmann A., Zimmermann M., Stanulla M., Schrappe M., Ludwig W., Bartram C. R., Radlwimmer B., Muckenthaler M. U., Lichter P. and Kulozik A. E. (20090921). High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. : Blood.

MLA

Remke Marc, Pfister Stefan, Kox Corinne, Toedt Grischa, Becker Natalia, Benner Axel, Werft Wiebke, Breit Stephen, Liu Shuangyou, Engel Felix, Wittmann Andrea, Zimmermann Martin, Stanulla Martin, Schrappe Martin, Ludwig Wolf-Dieter, Bartram Claus R, Radlwimmer Bernhard, Muckenthaler Martina U, Lichter Peter and Kulozik Andreas E. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. : Blood. 20090921.